• Fri news: New Novo obesity prospect linked to psychiatric side effects. Summit beats Keytruda in NSCLC. DermaSensor skin cancer detection device. Astellas digital health product. Sanofi MS data. See more on our front page

What is new with your awful company?


<











It is not that we discriminate.

It is that, once people reach about 35, they realize that the industry is a total scam, and they just can't drink the Kool Aid anymore.